Evidence map›Paper›PMID 40010774›Full record

ArticleJournal for immunotherapy of cancer2025

Effector T cells under hypoxia have an altered transcriptome similar to tumor-stressed T cells found in non-responsive melanoma patients.

Mate Z Nagy, Lourdes B Plaza-Rojas, Justin C Boucher, Elena Kostenko, Anna L Austin, Ahmad A Tarhini, Zhihua Chen, Dongliang Du, Awino Maureiq E Ojwang', Joshua Davis and 4 more

Abstract read
In one paragraph

Article in Journal for immunotherapy of cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Mate Z NagyDepartment of Immunology, H Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.
Lourdes B Plaza-RojasDepartment of Immunology, H Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.
Justin C BoucherDepartment of Immunology, H Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.ORCID http://orcid.org/0009-0008-8936-0470
Elena KostenkoDepartment of Immunology, H Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.
Anna L AustinDepartment of Immunology, H Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.
Ahmad A TarhiniDepartments of Cutaneous Oncology and Immunology, H Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.ORCID http://orcid.org/0000-0002-3193-9702
Zhihua ChenDepartment of Biostatistics and Bioinformatics, H Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.
Dongliang DuDepartment of Biostatistics and Bioinformatics, H Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.
Awino Maureiq E Ojwang'Department of Biostatistics and Bioinformatics, H Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.
Joshua DavisDepartment of Biostatistics and Bioinformatics, H Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.
Alyssa ObermayerDepartment of Biostatistics and Bioinformatics, H Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.
Katarzyna A RejniakDepartment of Integrated Mathematical Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Timothy I ShawDepartment of Biostatistics and Bioinformatics, H Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.
Jose A Guevara-PatinoDepartment of Immunology, H Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA JoseAlejandro.Guevara@moffitt.org.ORCID http://orcid.org/0000-0002-6258-7228

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI Christine O'Connell · 1998 to 2026
$93.5M
Modeling the role and regulation of reactive stroma in breast ductal carcinoma microinvasionsR01CA272601 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI DAMAGHI, MEHDI, REJNIAK, KATARZYNA ANNA · 2022 to 2025
$2.9M
Mathematical Model-Guided Adoptive Immunotherapy in Bladder CancerR01CA259387 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI PILON-THOMAS, SHARI, REJNIAK, KATARZYNA ANNA · 2021 to 2025
$2.3M
Study of Anti-Tumor Immunity and Tissue Resident Memory Cell Development by NKG2D and Ribosomal Protein S6 Signaling in T cellsR01CA250514 · NCI · LOYOLA UNIVERSITY CHICAGO · PI GUEVARA-PATINO, JOSE ALEJANDRO · 2020 to 2024
$1.8M
Integrated Program in Cancer and Data Science (ICADS)T32CA233399 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI William Douglas Cress, Elsa R Flores · 2019 to 2026
$1.7M
NCI NIH HHS P30 CA076292NCI NIH HHS R01 CA250514NCI NIH HHS R01 CA259387NCI NIH HHS R01 CA272601NCI NIH HHS T32 CA233399
6 · The paper itself

Abstract

backgroundIn the tumor microenvironment (TME), hypoxia stands as a significant factor that modulates immune responses, especially those driven by T cells. As T cell-based therapies often fail to work in solid tumors, this study aims to investigate the effects of hypoxia on T cell topo-distribution in the TME, gene expression association with T cell states, and clinical responses in melanoma.

methodsTo generate detailed information on tumor oxygenation and T cell accessibility, we used mathematical modeling of human melanoma tissue microarrays that incorporate oxygen supply from vessels, intratumoral diffusion, and cellular uptake. We created tumor maps and derived plots showing the fraction of CD4 and CD8 T cells against the distance to the nearest vessel and oxygen pressure. To assess their function and transcriptional changes caused by hypoxia, effector T cells were generated and cultured under hypoxia (0.5% oxygen) or normoxia (21% oxygen). The T cell hypoxia-transcriptional signature was compared against datasets from msigDB, iATLAS (clinical trials of melanoma patients treated with immune checkpoint inhibitors (ICIs)), ORIEN AVATAR (real-world melanoma patients treated with ICIs), and a single-cell atlas of tumor-infiltrating lymphocytes.

resultsWe made three specific observations: (1) in melanoma T cells preferentially accumulated in oxygenated areas close to blood vessels (50-100 µm from the vasculature in the regions of high oxygen availability) but not in hypoxic areas far from blood vessels. (2) Our analysis confirmed that under hypoxia, T cell functions were significantly reduced compared with normoxic conditions and accompanied by a unique gene signature. Furthermore, this hypoxic gene signature was prevalent in resting and non-activated T cells. Notably and clinically relevant, the hypoxic T cell gene set was found to correlate with reduced overall survival and reduced progression-free survival in melanoma patients, which was more pronounced in non-responder patients undergoing ICI therapy. (3) Finally, compared with a single-cell atlas of tumor-infiltrating T cells, our hypoxia signature aligned with a population of cells at a state termed stress response state (T

conclusionsOur study highlights the critical role of hypoxia in shaping T cell distribution and its correlation with clinical outcomes in melanoma. We revealed a preferential accumulation of T cells in oxygenated areas. Moreover, hypoxic T cells develop a distinct hypoxic gene signature prevalent in resting, non-activated T cells and T

Indexed as

MelanomaTranscriptomeHumansLymphocytes, Tumor-InfiltratingTumor MicroenvironmentGene expression profiling - GEPImmune Checkpoint InhibitorMelanomaTumor infiltrating lymphocyte - TILTumor microenvironment - TME

Identifiers

PMID40010774
PMCPMC12086921

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.